Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Clayer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
ANZ Journal of Surgery|August 19, 2006
Lytic bone lesions in an Australian population: the results of 100 consecutive biopsiesMark T Clayer
The Medical Journal of Australia|October 17, 2007
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregiversMark T Clayer
Acta Orthopaedica|October 30, 2007
Low risk of cardiac events during intramedullary instrumentation of lung cancer metastasesMark T Clayer, Xiaodong Tang
Journal of Shoulder and Elbow Surgery|September 28, 2010
Distal biceps tendon partial tear presenting as a pseudotumorAnthony R Bradshaw, Michael J Sandow, Mark T Clayer
Scientific Reports|August 28, 2015
Erratum: XI-006 induces potent p53-independent apoptosis in Ewing sarcomaKathleen I Pishas, Alaknanda Adwal, Susan J Neuhaus, et al.
Scientific Reports|June 23, 2015
XI-006 induces potent p53-independent apoptosis in Ewing sarcomaKathleen I Pishas, Alaknanda Adwal, Susan J Neuhaus, et al.
Oncology Reports|May 15, 2013
Pre-activation of the p53 pathway through Nutlin-3a sensitises sarcomas to drozitumab therapyKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
Cancer Research|December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
ANZ Journal of Surgery|August 19, 2006
Lytic bone lesions in an Australian population: the results of 100 consecutive biopsiesMark T Clayer
The Medical Journal of Australia|October 17, 2007
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregiversMark T Clayer
Acta Orthopaedica|October 30, 2007
Low risk of cardiac events during intramedullary instrumentation of lung cancer metastasesMark T Clayer, Xiaodong Tang
Journal of Shoulder and Elbow Surgery|September 28, 2010
Distal biceps tendon partial tear presenting as a pseudotumorAnthony R Bradshaw, Michael J Sandow, Mark T Clayer
Scientific Reports|August 28, 2015
Erratum: XI-006 induces potent p53-independent apoptosis in Ewing sarcomaKathleen I Pishas, Alaknanda Adwal, Susan J Neuhaus, et al.
Scientific Reports|June 23, 2015
XI-006 induces potent p53-independent apoptosis in Ewing sarcomaKathleen I Pishas, Alaknanda Adwal, Susan J Neuhaus, et al.
Oncology Reports|May 15, 2013
Pre-activation of the p53 pathway through Nutlin-3a sensitises sarcomas to drozitumab therapyKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
Cancer Research|December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
Pageof 1